Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia

Author: Hofmann W.   Heil G.   Zander C.   Wiebe S.   Ottmann O.   Bergmann L.   Hoeffken K.   Fischer J.   Knuth A.   Kolbe K.   Schmoll H.   Langer W.   Westerhausen M.   Koelbel C.   Hoelzer D.   Ganser A.  

Publisher: Springer Publishing Company

ISSN: 0939-5555

Source: Annals of Hematology, Vol.83, Iss.8, 2004-08, pp. : 498-503

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content